Markets
Elevance Health dives on outlook for post-Big Beautiful Bill world
(Samuel Corum/Getty Images)

ACA insurers drop as “beautiful” GOP law hits

Insurers that provide ACA coverage are getting battered after Elevance Health warned on the outlook for the market.

Health insurers that supply coverage to Affordable Care Act marketplaces, where some 24 million Americans get their health insurance, posted the ugliest losses in the S&P 500 on Friday, after one such insurer, Elevance Health, reported disappointing Q2 earnings and said it was raising premiums for such policies.

Elevance was the worst-performing stock in the S&P 500 for most of the first half of the day, before it was overtaken by Molina Healthcare, a similar insurer. Centene, another provider of government-related insurance, also tumbled.

Elevance’s Q2 numbers, released after the close of trading Thursday, weren’t horrible. They only just fell shy of Wall Street’s consensus expectation ($8.84 vs. $8.91). Sales of $49.42 billion were a bit better than expected.

But the company signaled growing uncertainty about its future, in part due to the “big, beautiful bill that passed the GOP-controlled Congress on a party-line vote and that President Trump signed into law early this month.

That bill lets the “enhanced subsides” for ACA marketplace buyers that began during the Covid crisis die at the end of the year.

According to the Congressional Budget Office, the loss of those enhanced subsidies is expected to knock roughly 4 million people off their ACA insurance in coming years.

This is a double whammy for insurers like Elevance. Obviously, it means fewer enrollees paying monthly premiums. But it also leaves insurers with a sicker client base and more expensive medical needs. (The people most likely to let their insurance lapse, even for reasons of affordability, tend to be those healthy enough to feel they can get away without coverage.)

“The biggest unknown for us right now is the policy uncertainties around the ultimate disposition of the enhanced subsidies in the individual ACA market,” Elevance CEO Gail Boudreaux told analysts after the company reported.

That said, the company is already raising the price of ACA individual insurance coverage to reflect the end of subsidies.

“Weve already repriced products for rising cost intensity,” Boudreaux said.

More Markets

See all Markets
markets

SpaceX gets a wave of bullish ratings from Wall Street analysts

SpaceX received more than a dozen positive analyst calls on Tuesday — including from major Wall Street banks — as they initiate coverage on Elon Musk’s space and AI company.

SpaceX went public on June 12 at a $2.2 trillion valuation, the largest debut in history. While the company hasn’t yet posted a profit, it seems to have convinced Wall Street that it will get there and grow its valuation on the way.

Of the at least 17 analysts that gave a rating on Tuesday, all but one gave it a “buy” or “outperform” rating. MoffettNathanson was "neutral."

The ratings come as SpaceX joined the Nasdaq 100 index, a benchmark tech-heavy basket of companies that underpins millions of portfolios. The inclusion adds built-in demand for the stock from index funds and ETFs.

Still, SpaceX fell more than 5% on Tuesday amid a broader sell-off, and is currently effectively flat from its opening price of $150 a share.

markets

Nike sinks to lowest level since 2014 after warning of “challenged” sales environment in Q4 report

Did Nike do it?

Investors had a mixed reaction after the global sports apparel company reported its fourth quarter earnings on Tuesday after the bell. Shares initially rose 5% as Nike beat out Wall Street expectations amid a hefty tariff refund bonus. However, the stock then sank to its lowest level since August 2014 in postmarket trading.

Here are the Q4 numbers:

  • Revenue of $11.0 billion (estimate: $10.8 billion).

  • Adjusted earnings per share of $0.20 (estimate: $0.12).

Ahead of this report, Nike warned that results would be flattered by a one-time tariff refund (now estimated at roughly $0.52 per share for the bottom line). That gave the company an extra cushion in snapping its streak of seven quarters of year-over-year profit declines.

Over the past year, the company had been punished by tariffs on imported goods, stagnant consumer spending, and increasing competition from other footwear brands like New Balance, Adidas, and Hoka.

Outgoing CFO Matthew Friend deemed it an “increasingly challenging operating environment, where sell-through remains challenged.”

Latest Stories

Sherwood Media, LLC and Chartr Limited produce fresh and unique perspectives on topical financial news and are fully owned subsidiaries of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, Robinhood Money, LLC, Robinhood U.K. Ltd, Robinhood Derivatives, LLC, Robinhood Gold, LLC, Robinhood Asset Management, LLC, Robinhood Credit, Inc., Robinhood Ventures DE, LLC and, where applicable, its managed investment vehicles.